Marshall Wace »

Rapt Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2025-09-30 $434k 17k 25.79

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms-a Common Stock (META)
Circle Internet Common Stock (CRCL)
Boston Scientifc Common Stock (BSX)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Adv Micro Device Common Stock (AMD)
Market Vectors S Equity Option Call Option (SMH)
Walmart Common Stock (WMT)
Johnson&johnson Common Stock (JNJ)
Cencora Common Stock (COR)

View all positions for Marshall Wace

Top funds holding Rapt Therapeutics

TCG Crossover Management
Foresite Capital Management VI
Rtw Investments
OrbiMed Advisors
Ikarian Capital
Boone Capital Management
Deep Track Capital
Vanguard Group
Nantahala Capital Management
Siren
Redmile Group
Soleus Capital Management
ADAR1 Capital Management
Fcpm Iii Services B.v.
Boothbay Fund Management

View all funds holding Rapt Therapeutics